Brawn Biotech Shareholding

Brawn Biotech Ltd Shareholding Pattern

The Brawn Biotech Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Brawn Biotech Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Brawn Biotech Ltd (NSE: , BSE: 530207) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Brawn Biotech Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Brawn Biotech Ltd Shareholding Pattern (Latest)

The latest Brawn Biotech Ltd shareholding for Dec 2025 is:

• Promoters: 53.39%
• FII: 0%
• DII: 0.35%
• Public: 46.26%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Brawn Biotech Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Brawn Biotech Ltd.

• Dec 2025: 53.39%
• Sept 2025: 53.66%
• Jun 2025: 53.66%
• Mar 2025: 53.66%
• Dec 2024: 53.64%

Promoter stake remains largely stable, showing consistent ownership structure.

Brawn Biotech Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Brawn Biotech Ltd.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Brawn Biotech Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0.35%
• Sept 2025: 0.35%
• Jun 2025: 0.35%
• Mar 2025: 0.35%
• Dec 2024: 0.35%

DII holdings remain stable, reflecting steady institutional participation.

Brawn Biotech Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 46.26%
• Sept 2025: 45.99%
• Jun 2025: 45.99%
• Mar 2025: 45.99%
• Dec 2024: 46.01%

Public participation in Brawn Biotech Ltd has increased, indicating rising retail investor interest.

Brawn Biotech Ltd Government Holding

Government holding in Brawn Biotech Ltd currently stands at 0%.

Brawn Biotech Ltd operates without significant government ownership.

Brawn Biotech Ltd Shareholding Analysis Summary

The Brawn Biotech Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Brawn Biotech Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Brawn Biotech Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.